BHVN Q4 2020 Earnings — Biohaven Ltd. Revenue & Financial Results | Market Cap Arena

BHVNBiohaven Ltd.

$1B

Q4 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$35M

Gross Profit

$25M71.6% margin

Operating Income

-$171M-486.1% margin

Net Income

-$218M-620.1% margin

EPS (Diluted)

$-4.49

QoQ Revenue Growth

+98.8%

Cash Flow

Operating Cash Flow

-$505M

Free Cash Flow

-$506M

Stock-Based Comp.

$33M

Balance Sheet

Total Assets

$111M

Total Liabilities

$35M

Stockholders' Equity

$17M

Cash & Equivalents

$83M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$35M	$0	—
Gross Profit	$25M	$0	—
Operating Income	-$171M	-$135M	-26.5%
Net Income	-$218M	-$149M	-45.9%